RBC Capital analyst Rishi Jaluria maintains Smartsheet (NYSE:SMAR) with a Sector Perform and raises the price target from $65 to $80.
Where Pear Therapeutics Stands With Analysts
Within the last quarter, Pear Therapeutics (NASDAQ:PEAR) has observed the following analyst ratings: